ColoSense

DEVICE2 trials

Sponsors

Geneoscopy, Inc.

Conditions

Advanced AdenocarcinomaColorectal CancerColorectal Cancer (Diagnosis)Serrated Polyp

Unknown Phase

Colorectal Cancer and Pre-Cancerous Adenoma Non-Invasive Detection Test Study

CompletedNCT04739722

Geneoscopy, Inc.Advanced Adenocarcinoma, Colorectal Cancer, Serrated Polyp

Start: 2021-04-12End: 2024-01-31Updated: 2024-10-01

ColoSense Post-Approval Study

RecruitingNCT07069556

Geneoscopy, Inc.Colorectal Cancer (Diagnosis)

Start: 2025-09-05End: 2030-09-01Target: 12500Updated: 2025-11-21

Related Papers

Multitarget Stool RNA Test for Colorectal Cancer Screening

JAMA2023-10-2399 citations

S317 CRC-PREVENT: Multi-Target Stool RNA Test for Detection of Colorectal Cancer and Advanced Adenomas in Average-Risk Individuals 45 and Older

The American Journal of Gastroenterology2023-10-01

S269 Utilizing a Decentralized Clinical Study Approach for Expedited and Diverse Recruitment for Clinical Validation of a Novel Non-invasive Multitargeted Stool-based RNA Test

The American Journal of Gastroenterology2022-10-01

CRC-PREVENT: Clinical validation trial to show expedited and diverse recruitment for the non-invasive RNA-FIT test that can detect advanced colorectal neoplasia with high sensitivity.

Journal of Clinical Oncology2022-01-19